New Orleans
,
USA
28 - 30 March 2026
American College of Cardiology (ACC 2026)
Presentation schedule and materials
Saturday, 28 March 2026
11:00
- 12:00
CST
1027-09
POSTER
Real-world disease progression in patients with transthyretin amyloid cardiomyopathy treated with tafamidis
Hanna K. Gaggin1; Weilong Li2; Monika Semwal2; Ashley Goss2; Myriam Asmar2; Chioma Uzoigwe2; Yan Wang3; Ariel Chao3; Yan Song4
MATERIALS AVAILABLE
13:35
- 13:42
CST
904-09
ORAL PRESENTATION
Effect of semaglutide on ankle-brachial index in people with peripheral artery disease and type 2 diabetes: An analysis of the STRIDE trial by disease severity
Marc Bonaca1; Andrei-Mircea Catarig2; Ecenur Guder Arslan2; Joakim Nordanstig3; Harald Sourij4; Sebastian Thomas5; Subodh Verma6
MATERIALS AVAILABLE
15:30
- 16:30
CST
1066-11
POSTER
Effect of oral semaglutide versus placebo on first and total MACE in SOUL trial participants with T2D and ASCVD and/or CKD
Nikolaus Marx1*; John E. Deanfield2*; Sharon L. Mulvagh3†; Silvio E. Inzucchi4; Rodica Pop-Busui5; Johannes F. E. Mann6,7; Neil R. Poulter8; G. Kees Hovingh9; Alex Videmark9; Zaklina Davicevic-Elez9; Derrick Musinga10; John B. Buse11; on behalf of the SOUL Study Group
MATERIALS AVAILABLE
Sunday, 29 March 2026
11:45
- 12:45
CST
Symposium
Unlocking CV inflammation in clinical practice
Paul M Ridker
;
Antonio Abbate
;
Giovanna Liuzzo
;
Guiomar Mendieta-Badimon
MATERIALS AVAILABLE
Coming soon
14:00
- 15:00
CST
1493-034
POSTER
Adherence to guidelines for primary and secondary prevention of atherosclerotic cardiovascular disease and chronic kidney disease: a real-world analysis
Chi Nguyen1; Guanghao Zhang1; Jeffrey R. Skaar1; Chioma Uzoigwe1; Libby Orzel1; Radha Ryali1; Charles A. Herzog2; Georges Nakhoul3
MATERIALS AVAILABLE
Keywords